www.patientpower.info
Open in
urlscan Pro
76.76.21.123
Public Scan
Submitted URL: http://patientpower.info/
Effective URL: https://www.patientpower.info/
Submission Tags: tranco_l324
Submission: On March 09 via api from DE — Scanned from DE
Effective URL: https://www.patientpower.info/
Submission Tags: tranco_l324
Submission: On March 09 via api from DE — Scanned from DE
Form analysis 1 forms found in the DOM
<form id="nav-search-form-id"></form>Text Content
* Cancer Types * Cancer Types * Navigating Cancer * Navigating Cancer * Living Well * Living Well * Events * Events Newsletters Chronic Lymphocytic Leukemia WHY OLDER PATIENTS WITH CLL STOP TAKING IBRUTINIB Real-world data published in a new report show most older patients taking ibrutinib (Imbruvica) for CLL stopped taking it within two years. Lung Cancer TEPOTINIB FULLY APPROVED FOR METASTATIC NSCLC Medically Reviewed: Natalie Vokes, MD Patients diagnosed with specific types of metastatic NSCLC will have continued access to tepotinib following the FDA’s regular approval of the oral medication. Multiple Myeloma NEW SECOND-LINE STANDARD IN R/R MYELOMA Medically Reviewed: David Dingli, MD, PhD, FRCP, FRCPEd, CBiol, FRSB, FRSM A combination therapy that uses belantamab slowed disease progression in patients with R/R multiple myeloma compared with standard treatment. Chronic Lymphocytic Leukemia NEW CLASS OF DRUGS FOR CLL ON THE HORIZON Medically Reviewed: Kerry A. Rogers, MD A Bruton’s tyrosine kinase degrader has shown promising results for patients whose chronic lymphocytic leukemia has relapsed or is resistant to other treatments. Breast Cancer MAJOR SHIFT IN BREAST CANCER RECOMMENDATIONS Medically Reviewed: Maryam Lustberg, MD, MPH New breast cancer recommendations call for BRCA1/2 mutation testing in all newly diagnosed patients aged 65 years or younger and certain older patients. EXPERT ADVICE YOU CAN TRUST * 20+Years Cancer Coverage * 200+Real Patient Stories * 1,000+Expert Contributors NAVIGATING CANCER View All Navigating Cancer BLOOD BASICS Our Blood Basics series goes deep into what’s in your blood and what it means when levels are high or low. Navigating Cancer YOUR QUESTIONS ANSWERED Real patients with cancer and caregivers submitted their questions, and we asked experts to respond. Navigating Cancer COVID-19 AND CANCER This is a multipart series exploring important questions about COVID-19 and its unique impact on people with cancer. CANCER TYPES Acute Myeloid Leukemia Breast Cancer Chronic Lymphocytic Leukemia Lung Cancer Multiple Myeloma Non-Hodgkin Lymphoma View All LIVING WELL View All Living Well FASTING AND CANCER: CAN IT HELP SLOW PROGRESSION? Medically Reviewed: Julie Lanford, MPH, RD, CSO, LDN Fasting may help fight cancer by reducing blood glucose levels, making it harder for cancer to grow. Learn more about the benefits, risk, and research. Living Well WILL HAVING A BLOOD CANCER AFFECT MY SEX LIFE? Medically Reviewed: Pankit Vachhani, MD Our expert helps people diagnosed with certain types of leukemia, lymphoma, and other blood cancers navigate sexual health challenges. Living Well CREAMY BANANA CINNAMON SMOOTHIE Medically Reviewed: Julie Lanford, MPH, RD, CSO, LDN Robert Kim credits this recipe with serving as the bridge to eventually eating a full diet after lung cancer surgery, because it allowed him to get used to flavors and scents again. He hopes to share it with other cancer survivors who are interested in finding fresh ways to keep bringing in calories. OUR NEWSLETTERS DELIVER THE LATEST CANCER NEWS DIRECTLY TO YOUR INBOX Sign up for our free newsletters. Sign Up ALL COVERAGE Multiple Myeloma FINDING MY MOM A MULTIPLE MYELOMA SPECIALIST A Patient Power producer becomes a care partner for her mom. Here’s why she made the decision to find her mom a multiple myeloma specialist. Multiple Myeloma FINDING MY MOM A MULTIPLE MYELOMA SPECIALIST A Patient Power producer becomes a care partner for her mom. Here’s why she made the decision to find her mom a multiple myeloma specialist. Chronic Lymphocytic Leukemia WHY OLDER PATIENTS WITH CLL STOP TAKING IBRUTINIB Real-world data published in a new report show most older patients taking ibrutinib (Imbruvica) for CLL stopped taking it within two years. Chronic Lymphocytic Leukemia WHY OLDER PATIENTS WITH CLL STOP TAKING IBRUTINIB Real-world data published in a new report show most older patients taking ibrutinib (Imbruvica) for CLL stopped taking it within two years. Multiple Myeloma BALANCING LIFE WITH TREATMENT Myeloma is a marathon and not a sprint. Yolanda Brunson-Sarrabo carefully considered what treatment options would best fit her lifestyle needs. Multiple Myeloma BALANCING LIFE WITH TREATMENT Myeloma is a marathon and not a sprint. Yolanda Brunson-Sarrabo carefully considered what treatment options would best fit her lifestyle needs. Multiple Myeloma MYELOMA CARE: FINDING YOUR VOICE After her multiple myeloma diagnosis, Yolanda Brunson-Sarrabo began to do her own research, ultimately realizing she was her own best advocate. Multiple Myeloma MYELOMA CARE: FINDING YOUR VOICE After her multiple myeloma diagnosis, Yolanda Brunson-Sarrabo began to do her own research, ultimately realizing she was her own best advocate. Systemic Mastocytosis EVENING WITH THE DOCS: FINDING A SM SPECIALIST In the on-demand content available from a recent Evening With the Docs systemic mastocytosis program, experts discuss how to find a specialist. Systemic Mastocytosis EVENING WITH THE DOCS: FINDING A SM SPECIALIST In the on-demand content available from a recent Evening With the Docs systemic mastocytosis program, experts discuss how to find a specialist. Systemic Mastocytosis EVENING WITH THE DOCS: SYSTEMIC MASTOCYTOSIS SYMPTOM MANAGEMENT In the on-demand content available from a recent Evening With the Docs Systemic Mastocytosis program, experts discuss how to manage and treat systemic mastocytosis symptoms. Systemic Mastocytosis EVENING WITH THE DOCS: SYSTEMIC MASTOCYTOSIS SYMPTOM MANAGEMENT In the on-demand content available from a recent Evening With the Docs Systemic Mastocytosis program, experts discuss how to manage and treat systemic mastocytosis symptoms. Systemic Mastocytosis EVENING WITH THE DOCS: DIAGNOSING SM In the on-demand content available from a recent Evening With the Docs systemic mastocytosis program, experts discuss how systemic mastocytosis is diagnosed, typed, and monitored. Systemic Mastocytosis EVENING WITH THE DOCS: DIAGNOSING SM In the on-demand content available from a recent Evening With the Docs systemic mastocytosis program, experts discuss how systemic mastocytosis is diagnosed, typed, and monitored. Breast Cancer LOBULAR CARCINOMA IN SITU: CAUSES, SYMPTOMS, AND TREATMENT Medically Reviewed: Maryam Lustberg, MD, MPH Lobular carcinoma in situ (LCIS) is a non-invasive breast condition where abnormal cells are found in the lobules of the breast. Breast Cancer LOBULAR CARCINOMA IN SITU: CAUSES, SYMPTOMS, AND TREATMENT Medically Reviewed: Maryam Lustberg, MD, MPH Lobular carcinoma in situ (LCIS) is a non-invasive breast condition where abnormal cells are found in the lobules of the breast. Endometrial Cancer ENDOMETRIAL BIOPSY: PURPOSE AND RESULTS Medically Reviewed: Uma Chandavarkar, MD, FACOG Endometrial biopsy is a procedure to collect a small tissue sample from the lining of the uterus for diagnosis. Endometrial Cancer ENDOMETRIAL BIOPSY: PURPOSE AND RESULTS Medically Reviewed: Uma Chandavarkar, MD, FACOG Endometrial biopsy is a procedure to collect a small tissue sample from the lining of the uterus for diagnosis. Breast Cancer WHAT ARE THE LATEST ADVANCES IN BREAST CANCER? Medically Reviewed: Maryam Lustberg, MD, MPH We spoke with experts to learn more about the latest advances in breast cancer, including advanced screening techniques and novel immunotherapies. Breast Cancer WHAT ARE THE LATEST ADVANCES IN BREAST CANCER? Medically Reviewed: Maryam Lustberg, MD, MPH We spoke with experts to learn more about the latest advances in breast cancer, including advanced screening techniques and novel immunotherapies. Prostate Cancer PROSTATE CANCER DRUG LINKED TO FATIGUE, DEPRESSION Medically Reviewed: Alberto Martini, MD A study presented at 2024 ASCO GU Symposium highlights that enzalutamide was linked with more fatigue and depression than abiraterone. Prostate Cancer PROSTATE CANCER DRUG LINKED TO FATIGUE, DEPRESSION Medically Reviewed: Alberto Martini, MD A study presented at 2024 ASCO GU Symposium highlights that enzalutamide was linked with more fatigue and depression than abiraterone. Prostate Cancer IS THIS PROSTATE CANCER DRUG COMBO BENEFICIAL ENOUGH? Medically Reviewed: Alberto Martini, MD A drug combo trial shows an increase of about two months survival in mCRPC. But experts are asking whether this is clinically meaningful. Prostate Cancer IS THIS PROSTATE CANCER DRUG COMBO BENEFICIAL ENOUGH? Medically Reviewed: Alberto Martini, MD A drug combo trial shows an increase of about two months survival in mCRPC. But experts are asking whether this is clinically meaningful. Load More EDITOR'S PICKS Thyroid Cancer PICTURING CANCER: LITTLE OCTOPUS Patient Stories “CANCER TALK:” WHY LANGUAGE MATTERS Medically Reviewed Care Partners CARE PARTNER BURNOUT: DO YOU HAVE IT? Medically Reviewed Patient Stories BEING EMPOWERED AND THEN EMPOWERING OTHERS SponsoredSystemic Mastocytosis AVAPRITINIB FOR INDOLENT SYSTEMIC MASTOCYTOSIS Medically Reviewed YOUR VOICE CAN HELP IMPROVE HEALTHCARE OUTCOMES Share your stories and affect positive change within healthcare. EDITOR'S PICKS Thyroid Cancer PICTURING CANCER: LITTLE OCTOPUS Patient Stories “CANCER TALK:” WHY LANGUAGE MATTERS Medically Reviewed Care Partners CARE PARTNER BURNOUT: DO YOU HAVE IT? Medically Reviewed Patient Stories BEING EMPOWERED AND THEN EMPOWERING OTHERS SponsoredSystemic Mastocytosis AVAPRITINIB FOR INDOLENT SYSTEMIC MASTOCYTOSIS Medically Reviewed CANCER NEWS IN YOUR INBOX… Newsletters FOLLOW US! * Share via facebook * Share via instagram * Share via twitter * About Us * Contact Us * Medical Review Board * Advisory Panel * Trusted Organizations * Patient Engagement * Advertise With Us * Sitemap * Our Other Sites * Advertising Policy * Do Not Sell My Info * Privacy Policy * Terms of Use © 2024 HealthCentral LLC. All rights reserved.